Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe

We report 2 cases of leishmaniasis in patients with autoimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Reports increased during 2004–2008, especially for patients treated with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xynos, Ioannis D., Tektonidou, Maria G., Pikazis, Dimitrios, Sipsas, Nikolaos V.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2009
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727307/
https://www.ncbi.nlm.nih.gov/pubmed/19523302
http://dx.doi.org/10.3201/eid1506.090101
_version_ 1782170659531522048
author Xynos, Ioannis D.
Tektonidou, Maria G.
Pikazis, Dimitrios
Sipsas, Nikolaos V.
author_facet Xynos, Ioannis D.
Tektonidou, Maria G.
Pikazis, Dimitrios
Sipsas, Nikolaos V.
author_sort Xynos, Ioannis D.
collection PubMed
description We report 2 cases of leishmaniasis in patients with autoimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Reports increased during 2004–2008, especially for patients treated with anti–tumor necrosis factor agents.
format Text
id pubmed-2727307
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-27273072009-08-25 Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe Xynos, Ioannis D. Tektonidou, Maria G. Pikazis, Dimitrios Sipsas, Nikolaos V. Emerg Infect Dis Dispatch We report 2 cases of leishmaniasis in patients with autoimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Reports increased during 2004–2008, especially for patients treated with anti–tumor necrosis factor agents. Centers for Disease Control and Prevention 2009-06 /pmc/articles/PMC2727307/ /pubmed/19523302 http://dx.doi.org/10.3201/eid1506.090101 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Xynos, Ioannis D.
Tektonidou, Maria G.
Pikazis, Dimitrios
Sipsas, Nikolaos V.
Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
title Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
title_full Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
title_fullStr Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
title_full_unstemmed Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
title_short Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
title_sort leishmaniasis, autoimmune rheumatic disease, and anti–tumor necrosis factor therapy, europe
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727307/
https://www.ncbi.nlm.nih.gov/pubmed/19523302
http://dx.doi.org/10.3201/eid1506.090101
work_keys_str_mv AT xynosioannisd leishmaniasisautoimmunerheumaticdiseaseandantitumornecrosisfactortherapyeurope
AT tektonidoumariag leishmaniasisautoimmunerheumaticdiseaseandantitumornecrosisfactortherapyeurope
AT pikazisdimitrios leishmaniasisautoimmunerheumaticdiseaseandantitumornecrosisfactortherapyeurope
AT sipsasnikolaosv leishmaniasisautoimmunerheumaticdiseaseandantitumornecrosisfactortherapyeurope

Ejemplares similares